Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Cancer treatments hiding in genome’s “dark matter”
Researchers of the University of Bern and the Insel Hospital, University Hospital Bern, Switzerland, have…
Dr Qi Fang: From the cosmos to cancer
Astrophysicist turned medical researcher wins Woodside Early Career Scientist of the Year at the WA…
Study validates diagnostic assay for Asian cancers
A Singapore research team of clinicians and scientists has validated a cancer diagnostic assay, designed…
Revealed: The gut microbe source of a carcinogenic, DNA-smashing genotoxin
A study published in Science has provided the first direct evidence of how a genotoxic warhead that can target and destroy the…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.